I just finished reading the new INJ whitepaper today, and honestly, this move by Injective (INJ) feels like an old tree sprouting new branches! Most people probably still think of INJ as a 'derivatives DEX public chain,' but after diving deeper recently, I realized they’ve quietly pulled off something big. They’ve released a completely revamped whitepaper—the first major update since 2018—repositioning themselves as a 'dedicated L1 for institutional-grade finance and RWA.' From asset issuance and on-chain order book trading to AI-driven financial agents and tokenized settlements, the entire lifecycle is designed specifically for RWAs and institutional entry points. And this isn’t just some whitepaper hype. After digging around, I found that their activity level over the past 6 weeks has been off the charts: 1️⃣ Full rollout of compliance and institutional channels: Meridian upgrade, SEC-registered transfer agent, MiCA filing, and even integration with Robinhood; 2️⃣ INJ ETF in progress: Both 21Shares and Canary have been submitting amendment filings for their INJ ETF applications, and the CEO revealed today that it’s launching very soon; 3️⃣ Extremely clean tokenomics: The token is already 100% fully circulated, with no VC unlock sell pressure, and the whitepaper explicitly mentions a buyback plan! A veteran public chain with a compliance moat, fully circulated tokens, and a completely overhauled technical whitepaper is quietly gearing up in the institutional RWA space. Could this be the next big revaluation play? DYOR and keep an eye on it! #INJ #Injective #RWA #Crypto